These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23971720)

  • 1. Berberis aristata/Silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients.
    Derosa G; Bonaventura A; Bianchi L; Romano D; D'Angelo A; Fogari E; Maffioli P
    Expert Opin Biol Ther; 2013 Nov; 13(11):1495-506. PubMed ID: 23971720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Berberis aristata/Silybum marianum association on metabolic parameters and adipocytokines in overweight dyslipidemic patients.
    Derosa G; Bonaventura A; Bianchi L; Romano D; D' Angelo A; Fogari E; Maffioli P
    J Biol Regul Homeost Agents; 2013; 27(3):717-28. PubMed ID: 24152839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberis aristata/Silybum marianum fixed combination (Berberol(®)) effects on lipid profile in dyslipidemic patients intolerant to statins at high dosages: a randomized, placebo-controlled, clinical trial.
    Derosa G; Romano D; D'Angelo A; Maffioli P
    Phytomedicine; 2015 Feb; 22(2):231-7. PubMed ID: 25765827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses.
    Derosa G; Romano D; D'Angelo A; Maffioli P
    Atherosclerosis; 2015 Mar; 239(1):87-92. PubMed ID: 25577665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of a fixed Berberis aristata/Silybum marianum combination in the treatment of type 1 diabetes mellitus.
    Derosa G; D'Angelo A; Maffioli P
    Clin Nutr; 2016 Oct; 35(5):1091-5. PubMed ID: 26384091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a Combination of Berberis aristata, Silybum marianum and Monacolin on Lipid Profile in Subjects at Low Cardiovascular Risk; A Double-Blind, Randomized, Placebo-Controlled Trial.
    Derosa G; D'Angelo A; Romano D; Maffioli P
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28178209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of a Fixed Combination of Berberis aristata and Silybum marianum on Dyslipidaemia - A Meta-analysis and Systematic Review.
    Tóth B; Németh D; Soós A; Hegyi P; Pham-Dobor G; Varga O; Varga V; Kiss T; Sarlós P; Erőss B; Csupor D
    Planta Med; 2020 Jan; 86(2):132-143. PubMed ID: 31784970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes.
    Di Pierro F; Putignano P; Villanova N; Montesi L; Moscatiello S; Marchesini G
    Clin Pharmacol; 2013; 5():167-74. PubMed ID: 24277991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioimpedance analysis, metabolic effects and safety of the association Berberis aristata/Bilybum marianum: a 52-week double-blind, placebo-controlled study in obese patients with type 2 diabetes.
    Guarino G; Strollo F; Carbone L; Della Corte T; Letizia M; Marino G; Gentile S
    J Biol Regul Homeost Agents; 2017; 31(2):495-502. PubMed ID: 28685558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, placebo-controlled study on the effects of a nutraceutical combination of red yeast rice, silybum marianum and octasonol on lipid profile, endothelial and inflammatory parameters.
    Derosa G; Bonaventura A; Bianchi L; Romano D; D'Angelo A; Fogari E; Maffioli P
    J Biol Regul Homeost Agents; 2014; 28(2):317-24. PubMed ID: 25001663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in diabetic patients with dyslipidemia.
    Di Pierro F; Putignano P; Villanova N
    Acta Biomed; 2018 Jan; 88(4):462-469. PubMed ID: 29350661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial.
    Trimarco V; Izzo R; Stabile E; Rozza F; Santoro M; Manzi MV; Serino F; Schiattarella GG; Esposito G; Trimarco B
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):149-54. PubMed ID: 25870124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower glycemic indices and lipid profile among type 2 diabetes mellitus patients who received novel dose of Silybum marianum (L.) Gaertn. (silymarin) extract supplement: A Triple-blinded randomized controlled clinical trial.
    Ebrahimpour-Koujan S; Gargari BP; Mobasseri M; Valizadeh H; Asghari-Jafarabadi M
    Phytomedicine; 2018 May; 44():39-44. PubMed ID: 29895491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutraceutical Effects on Glucose and Lipid Metabolism in Patients with Impaired Fasting Glucose: A Pilot, Double-Blind, Placebo-Controlled, Randomized Clinical Trial on a Combined Product.
    Cicero AFG; Fogacci F; Morbini M; Colletti A; Bove M; Veronesi M; Giovannini M; Borghi C
    High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):283-288. PubMed ID: 28537012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins.
    Di Pierro F; Bellone I; Rapacioli G; Putignano P
    Diabetes Metab Syndr Obes; 2015; 8():89-96. PubMed ID: 25678808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial.
    Panahi Y; Khalili N; Sahebi E; Namazi S; Reiner Ž; Majeed M; Sahebkar A
    Complement Ther Med; 2017 Aug; 33():1-5. PubMed ID: 28735818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
    Zhang P; Yang C; Guo H; Wang J; Lin S; Li H; Yang Y; Ling W
    J Clin Lipidol; 2018; 12(2):417-427.e5. PubMed ID: 29454678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-arm, placebo-controlled, randomized clinical trial evaluating the metabolic effect of a combined nutraceutical containing a bergamot standardized flavonoid extract in dyslipidemic overweight subjects.
    Cicero AFG; Fogacci F; Bove M; Giovannini M; Borghi C
    Phytother Res; 2019 Aug; 33(8):2094-2101. PubMed ID: 31225673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies on rabbit plasma lipid profile fed with Silybum marianum oil, sunflower oil and vegetable ghee.
    Lutfullah G; Rahman A; Ahmad A; Ahmad T; Ali A; Alam J
    Pak J Pharm Sci; 2017 May; 30(3):875-879. PubMed ID: 28653933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chia induces clinically discrete weight loss and improves lipid profile only in altered previous values.
    Tavares Toscano L; Tavares Toscano L; Leite Tavares R; da Oliveira Silva CS; Silva AS
    Nutr Hosp; 2014 Dec; 31(3):1176-82. PubMed ID: 25726210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.